Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epinephrine vs Oxymetazoline for Epistaxis in Nasal Intubation
NCT06789549Phase 2Completed
- Sponsor
- Universitas Padjadjaran
- Start
- Jan 2024
- Primary completion
- Mar 2024
- Modality
- Orthosteric Ligands, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of epinephrine nasal spray in epistaxis, sponsored by Universitas Padjadjaran. Started Jan 2024; status: completed.
02
Drugs
epinephrine nasal spray
03
Conditions
epistaxis
Beyond the preview
Go deeper on NCT06789549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06789549.